Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-03-14Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: a Randomized Comparison of Aripiprazole, Quetiapine and Ziprasidone Over 1 Year
-
CLINICAL_TRIALS study record update · 2017-03-14Phase IV Study of the Effectiveness of Aripiprazole, Quetiapine, and Ziprasidone in the Treatment of First Episode of Non-affective Psychosis Individuals Included in the First Episode Psychosis Clinical Program II (PAFIP II)
-
CLINICAL_TRIALS study record update · 2017-03-13The Immune System and Psychiatric Disorders
-
CLINICAL_TRIALS study record update · 2017-03-10Canadian Non-Interventional Prospective Cohort Study on the Real - Life Assessment of Abilify Maintena ™ in Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-03-10An Open-Label Positron Emission Tomography (PET) Study to Demonstrate Receptor Occupancy, Safety, Tolerability and Pharmacokinetics of ITI-007 in Stable Schizophrenia Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-03-09Integration of Illness Management and Recovery Within ACT
-
CLINICAL_TRIALS study record update · 2017-03-03Effects of RG1068 (Secretin) on Information Processing in Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-03-01Anodal & Cathodal tDCS for Treatment of Resistant Auditory Hallucinations in Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-02-23Interventional, Open-label, Flexible-dose Extension Study of Brexpiprazole in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-02-17BDNF as a Potential Biomarker for Cognitive Remediation Therapy in Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-02-16Arithmetic Calculation Training With the Kumon Errorless Learning Method for Cognitive Rehabilitation of Patients With Schizophrenia: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2017-02-15A Phase 1, Multicenter, Open-label, Dose-Escalation Trial to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-02-15A Phase III, Multi-Center, Randomized, 24 Week, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate Efficacy and Safety of RO4917838 in Stable Patients With Persistent, Predominant Negative Symptoms of Schizophrenia Treated With Antipsychotics Followed by a 28 Week, Double-Blind Treatment Period
-
CLINICAL_TRIALS study record update · 2017-02-10Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-02-09A Randomized, Rater-Blind, Controlled, Clinical Trial of Conversion to Antipsychotic Monotherapy vs. Continued Polypharmacy for Patients With Schizophrenia or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2017-02-07Evaluation of the Efficacy of Metformin for Weight Loss and Metabolic Effects In Overweight Psychiatric Patients Treated With Antipsychotic Medication
-
CLINICAL_TRIALS study record update · 2017-02-01Detecting Which Patients With Schizophrenia Will Improve With Omega-3 Treatment
-
CLINICAL_TRIALS study record update · 2017-01-31A Multicenter, Randomized, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of RBP-7000 Using Poly (DL-lactide-co-glycolide) Polymer of Two Different Molecular Weights (Low and High Molecular Weights as Test Treatments) Compared to Intermediate Molecular Weight (Reference Treatment) Polymer in Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-01-31Coronary Artery Disease as a Cause of Morbidity and Mortality in Patients Suffering From Schizophrenia: Epidemiology and Status to Provide Prevention, Interventions and Treatment
-
CLINICAL_TRIALS study record update · 2017-01-27Evaluating the Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia: Implications for Treatment
-
CLINICAL_TRIALS study record update · 2017-01-27A Multicenter Ascending Dose, Double Blind, Placebo-controlled Study of NAP (AL-108) in Chronic Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-01-26Continued Early Intervention for Recent-onset Schizophrenia. A Randomized Controlled Study.
-
CLINICAL_TRIALS study record update · 2017-01-24A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse
-
CLINICAL_TRIALS study record update · 2017-01-13Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Negative Symptoms and Social Dysfunction in Schizophrenia Patients
-
CLINICAL_TRIALS study record update · 2017-01-12Transdermal Nicotine and Bupropion for Smoking in Schizophrenics (Study 1)